Rockville-based Institutional Shareholder Service supports BioVeris

BioVeris Corp.'s shareholders should vote in favor of the company's pending merger with a subsidiary of Roche Holding AG, a second proxy advisory firm said. The recommendation from Rockville- based Institutional Shareholder Services, a provider of proxy voting and corporate governance data services, follows the same advice from Glass Lewis & Co.

earlier this week, Gaithersburg-basedBioVeris said. Shareholders are scheduled to vote on the merger June 25, the company said. Roche, the world's biggest maker of diagnostic tests, agreed in April to pay $600 million, or $21.50 a share, to acquire BioVeris, which makes products for the clinical diagnostic, biodefense and life sciences industries.

Copyright 2007 Dolan Media Newswires
Provided by ProQuest Information and Learning Company. All rights Reserved.